A team of researchers has found a way to steer the output of large language models by manipulating specific concepts inside ...

Nvidia sold its entire 7.71M share stake as ARK Invest bought 1.25M shares; RXRX swung 14% before closing 2% higher Wednesday.

If you are trying to figure out whether Recursion Pharmaceuticals is attractively priced or a high risk speculation, a useful starting point is understanding what the current market price might be ...

If you’re on any form of social media, there’s a very good chance you will have recently been harangued by videos of very fit looking people extolling the virtues of the ‘Tai Chi walking method’. This ...

All opinions, columns and letters reflect the views of the individual writer and not necessarily those of the IDS or its staffers. Whether your New Year’s resolution was to lock in this semester, ...

Ukrainians resist even in occupied areas: "Any sign of loyalty can mean death" Bear Grylls: My father’s death took me to my knees, I was so ill-prepared Greenland protesters mock Trump with their own ...

Dean J. Miller does not work for, consult, own shares in or receive funding from any company or organization that would benefit from this article, and has disclosed no relevant affiliations beyond ...

Editor’s note: This story is part of Peak, The Athletic’s desk covering leadership, personal development and performance through the lens of sports. Follow Peak here. Joe Boylan worked in the NBA for ...

In a recent social media post, Peter Ray, senior director of medicinal chemistry at Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX), drew attention to a new article in WIRED from Veronique Greenwood ...

Jeff Somers is a freelancer who has been writing about writing, books, personal finance, and home maintenance since 2012. When not writing, Jeff spends his free time fixing up his old house. He has ...